• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec8
Cardiff Oncology to present new clinical data on onvansertib at ASH annual meeting
21:05
Nov7
Cardiff Oncology released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 120 K (forecast USD 121.43 K), actual EPS USD -0.1684 (forecast USD -0.205)
04:00
Cardiff Oncology released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 350K, actual EPS USD -0.5801
04:00
Jul30
Cardiff Oncology released FY2025 Semi-Annual earnings on July 29 (EST), actual revenue USD 230K, actual EPS USD -0.4117
03:00
Cardiff Oncology released FY2025 Q2 earnings on July 29, 2025 (EST), with actual revenue of USD 121 K (forecast USD 106.25 K) and actual EPS of USD -0.2096 (forecast USD -0.1925)
03:00
Jun26
Cardiff Oncology Annual Shareholder Meeting Appoints Registered Independent Auditor and Amends Equity Incentive Plan
20:31

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 120 K, Net Income -11.26 M, EPS -0.1684

Jul29
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 121 K, Net Income -13.95 M, EPS -0.2096

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 109 K, Net Income -13.44 M, EPS -0.202

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More